Please use this identifier to cite or link to this item:
http://hdl.handle.net/1942/33916
Title: | The hepatitis C cascade of care in the Belgian HIV population: one step closer to elimination | Authors: | BUSSCHOTS, Dana KREMER, Cécile KOC, Ozgur HEYENS, Leen BIELEN, Rob Apers, Ludwig Florence, Eric MESSIAEN, Peter Van Laethem, Kristel Van Wijngaerden, Eric Nevens, Frederik HENS, Niel ROBAEYS, Geert |
Issue Date: | 2021 | Publisher: | ELSEVIER SCI LTD | Source: | INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 105 , p. 217 -223 | Abstract: | Objectives The Belgian population of people living with HIV (PLHIV) has unrestricted access to direct-acting antiviral (DAA) treatment for hepatitis C virus (HCV) infection, since 2017. International literature claims that half of the patients remain untreated in high-income countries with unrestricted access to DAA. This study was initiated to provide an overview of the present situation in Belgium and recommendations for HCV care in PLHIV in other regions. Methods This was a retrospective, multicenter study of PLHIV in Belgium, from January 1, 2007 to December 31, 2018. The HCV cascade of care was examined. Results Out of 4607 unique PLHIV, 322 (7.0%) tested positive for HCV antibody and HCV RNA positivity was seen in 289 (6.3%). Of those with a proven HCV infection, 207/289 (71.6%) initiated treatment. Of the 171 (82.6%) persons with a sustained virologic response (SVR), 16 (9.4%) subjects were reinfected. Conclusions We present a care cascade of 4607 PLHIV in Belgium. Treatment initiation and SVR rates were high compared to other regions. Implementation of a national HCV register to track progress and yearly screening, especially in PLHIV with high-risk behavior, remains crucial. Identifying reasons for not initiating treatment is necessary to achieve elimination of HCV in PLHIV by 2030. | Keywords: | Hepatitis C;HIV;Cascade of care;Treatment;Recommendations;High-income country | Document URI: | http://hdl.handle.net/1942/33916 | ISSN: | 1201-9712 | e-ISSN: | 1878-3511 | DOI: | 10.1016/j.ijid.2021.02.068 | ISI #: | 000680208600034 | Rights: | 2021 The Authors. Published by Elsevier Ltd on behalf of International Society for Infectious Diseases. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/). | Category: | A1 | Type: | Journal Contribution | Validations: | ecoom 2022 |
Appears in Collections: | Research publications |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
PIIS1201971221001545.pdf | Published version | 748.7 kB | Adobe PDF | View/Open |
WEB OF SCIENCETM
Citations
6
checked on Sep 13, 2024
Page view(s)
34
checked on Jun 14, 2022
Download(s)
14
checked on Jun 14, 2022
Google ScholarTM
Check
Altmetric
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.